Who are Antimicrobial agent's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Chlorhexidine gluconate (4%), Halometasone Triclosan, Irrigation with PVI, PerioChip ®, Chlorhexidine oral care, Silver sulfadiazine ointment.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/antimicrobial-agent.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Antimicrobial agent — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Antimicrobial agent (Antimicrobial agent) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimicrobial agent. Area: Infectious Diseases.

phase 2 Antimicrobial agent Infectious Diseases Small molecule Live · refreshed every 30 min

Target snapshot

Antimicrobial agent (Antimicrobial agent) — Universidad Miguel Hernandez de Elche. Antimicrobial agents work by inhibiting bacterial cell wall synthesis, protein synthesis, or interfering with essential bacterial processes.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Antimicrobial agent TARGET	Antimicrobial agent	Universidad Miguel Hernandez de Elche	phase 2	Antimicrobial agent
Chlorhexidine gluconate (4%)	Chlorhexidine gluconate (4%)	The Cooper Health System	marketed	Antimicrobial agent / Antiseptic
Halometasone Triclosan	Halometasone Triclosan	Beijing Friendship Hospital	marketed	Topical corticosteroid with antimicrobial agent	Glucocorticoid receptor (halometasone); bacterial enoyl-ACP reductase (triclosan)
Irrigation with PVI	Irrigation with PVI	The University of Texas Health Science Center, Houston	marketed	Antiseptic/Antimicrobial agent
PerioChip ®	PerioChip ®	Dexcel Pharma Technologies Ltd.	marketed	Local antimicrobial agent	Bacterial cell membranes (chlorhexidine non-specific antimicrobial)
Chlorhexidine oral care	Chlorhexidine oral care	University of Pavia	marketed	Antimicrobial agent / Antiseptic	Bacterial cell membrane and proteins
Silver sulfadiazine ointment	Silver sulfadiazine ointment	SCARM Institute, Tabriz, Iran	marketed	Topical antimicrobial agent	Bacterial cell wall and DNA; dihydropteroate synthase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimicrobial agent class)

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class
SIFI SpA · 1 drug in this class
Universidad Miguel Hernandez de Elche · 1 drug in this class
University of Sorocaba · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Antimicrobial agent — Competitive Intelligence Brief. https://druglandscape.com/ci/antimicrobial-agent. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing